Pubblicazioni

Sequential treatment with regorafenib and trifluridine/tipiracil in later-line refractory metastatic colorectal cancer: A real-world multicenter retrospective study

2023 - JOURNAL OF CLINICAL ONCOLOGY
Signorelli, Carlo; Schirripa, Marta; Chilelli, Mario Giovanni; Calegari, Maria Alessandra; Basso, Michele; Anghelone, Annunziato; Lucchetti, Jessica; Minelli, Alessandro; Angotti, Lorenzo; Gemma, Donatello; Dell'Aquila, Emanuela; Cosimati, Antonella; Arrivi, Giulia; Morelli, Cristina; Corsi, Domenico Cristiano; Saltarelli, Rosa; Morandi, Maria Grazia; Zoratto, Federica; Santamaria, Fiorenza; Ruggeri, Enzo Maria

Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC

2023 - JOURNAL OF CLINICAL ONCOLOGY
Bote, Helena; Siringo, Marco; García-Lorenzo, Esther; Castelo, Alicia; Conde, Esther; Hernández, Susana; Herrera, Mercedes; Ruano-Domínguez, Yolanda; Baena, Javier; Enguita, Ana Belén; Lopez-Rios Moreno, Fernando; Zugazagoitia, Jon; Paz-Ares, Luis G.

Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: The IMMINENT study

2023 - JOURNAL OF CLINICAL ONCOLOGY
Sposito, Marco; Belluomini, Lorenzo; Insolda, Jessica; Dodi, Alessandra; Aprile, Giuseppe; Veccia, Antonello; Caffo, Orazio; Soto Parra, Hector Josè; Lombardo, Fiorella; Lugini, Antonio; Occhipinti, Mario; Ferrau, Francesco; Savastano, Clementina; Verderame, Francesco; Bria, Emilio; Novello, Silvia; Malapelle, Umberto; Pilotto, Sara; Milella, Michele

Immunotherapy and chemo-immunotherapy for non–small cell lung cancer with novel actionable oncogenic driver alterations.

2022 - JOURNAL OF CLINICAL ONCOLOGY
Mazzeo, Laura; Beninato, Teresa; Carlotta Pircher, Chiara; Brambilla, Marta; Manglaviti, Sara; De Toma, Alessandro; Galli, Giulia; Prelaj, Arsela; Ferrara, Roberto; Proto, Claudia; Lo Russo, Giuseppe; Ganzinelli, Monica; Chiara Garassino, Marina; Marchetti, Paolo; G De Braud, Filippo; Occhipinti, Mario

Clinical outcomes of metastatic renal carcinoma following disease progression to programmed death (PD)-1 or PD-L1 inhibitors (I-O): A Meet-URO group real-world study (Meet-Uro 7)

2020 - JOURNAL OF CLINICAL ONCOLOGY
Santini, Daniele; Stellato, Marco; De Giorgi, Ugo; Pignata, Sandro; Pantano, Francesco; De Lisi, Delia; Casadei, Chiara; Maruzzo, Marco; Naglieri, Emanuele; Buti, Sebastiano; De Vivo, Rocco; Di Lorenzo, Giuseppe; Sbrana, Andrea; Soraru', Mariella; Fornarini, Giuseppe; Mucciarini, Claudia; Grillone, Francesco; Roviello, Giandomenico; Vignani, Francesca; Procopio, Giuseppe

Role of glyoxalase-1 in trabectedin-resistant myxoid liposarcoma

2020 - JOURNAL OF CLINICAL ONCOLOGY
Simonetti, Sonia; Iuliani, Michele; Pantano, Francesco; Ribelli, Giulia; Napolitano, Andrea; Santini, Daniele; Tonini, Giuseppe; Vincenzi, Bruno

The prognostic value of patient-reported outcomes (PROs) for survival outcomes in cancer patients: A systematic review

2019 - JOURNAL OF CLINICAL ONCOLOGY
Cottone, Francesco; Collins, Gary S.; Giesinger, Johannes M.; Sommer, Kathrin; Deliu, Nina; Vignetti, Marco; Anota, Amelie; Efficace, Fabio

CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach

2019 - JOURNAL OF CLINICAL ONCOLOGY
Giusti, Raffaele; Mazzotta, Marco; Filetti, Marco; Marinelli, Daniele; Di Napoli, Arianna; Scarpino, Stefania; Scafetta, Giorgia; Mei, Monica; Vecchione, Andrea; Ruco, Luigi; Marchetti, Paolo

Pretreatment symptom prevalence in patients with myelodysplastic syndromes (MDS) across all disease risk categories: Analysis of 914 patients

2019 - JOURNAL OF CLINICAL ONCOLOGY
Efficace, Fabio; Niscola, Pasquale; Patriarca, Andrea; Cottone, Francesco; Palumbo, Giuseppe A.; Breccia, Massimo; Caocci, Giovanni; Platzbecker, Uwe; Specchia, Giorgina; Stauder, Reinhard; Fianchi, Luana; Sanpaolo, Grazia; Petranovic, Duska; Frairia, Chiara; Caers, Jo; Santini, Valeria; Bergamaschi, Micaela; Capodanno, Isabella; Di Renzo, Nicola; Vignetti, Marco

Fatigue in long-term survivors of acute promyelocytic leukemia (APL) and its association with other symptoms and functional limitations

2019 - JOURNAL OF CLINICAL ONCOLOGY
Efficace, Fabio; Breccia, Massimo; Avvisati, Giuseppe; Cottone, Francesco; Intermesoli, Tamara; Borlenghi, Erika; Carluccio, Paola; Rodeghiero, Francesco; Fabbiano, Francesco; Luppi, Mario; Romani, Claudio; Sborgia, Marco; D'Ardia, Stefano; Nobile, Francesco; Cantore, Nicola; Crugnola, Monica; Nadali, Gianpaolo; Amadori, Sergio; Vignetti, Marco; LO COCO, Francesco

Effect of nutritional support with highly purified, whey proteins for malnutrition and sarcopenia in patients affected with stage II-III colorectal or breast cancer: A blind, placebo controlled, randomized clinical trial

2018 - JOURNAL OF CLINICAL ONCOLOGY
Mazzuca, F; Roberto, M; Botticelli, A; Marchetti, L; Sarfati, E; Crimini, E; Schipilliti, Fm; DI GIROLAMO, Marco; Muscaritoli, M; Marchetti, Paolo

Effects of cabozantinib on bone turnover markers in patients with metastatic renal cell carcinoma

2018 - JOURNAL OF CLINICAL ONCOLOGY
Ratta, Raffaele; Verzoni, Elena; Pantano, Francesco; Grassi, Paolo; Martinetti, Antonia; Morelli, Daniele; Sottotetti, Elisa; Mennitto, Roberta; Fucà, Giovanni; Prisciandaro, Michele; De Braud, Filippo G.; Santini, Daniele; Procopio, Giuseppe

Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients

2017 - JOURNAL OF CLINICAL ONCOLOGY
Nuti, M; Zizzari, I; Napoletano, C; Botticelli, A; Calabro, F; Gelibter, A; Rughetti, A; Ugolini, A; Ruscito, I; Mazzuca, F; Rahimi, H; Onesti, Ce; Cortesi, E; Marchetti, P

M1-polarized macrophages as predictor of poor response to trabectedin treatment in myxoid liposarcoma

2016 - JOURNAL OF CLINICAL ONCOLOGY
Vincenzi, Bruno; Fioramonti, Marco; Iuliani, Michele; Pantano, Francesco; Ribelli, Giulia; Santini, Daniele; Tonini, Giuseppe

Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma

2016 - JOURNAL OF CLINICAL ONCOLOGY
Vincenzi, Bruno; Stacchiotti, Silvia; Collini, Paola; Pantano, Francesco; Perrone, Giuseppe; Iuliani, Michele; Baldi, Alfonso; Badalamenti, Giuseppe; Sanfilippo, Roberta; Santini, Daniele; Onetti-Muda, Andrea; Gronchi, Alessandro; Casali, Paolo Giovanni; Dei Tos, Angelo Paolo; Tonini, Giuseppe

Biological effects of cabozantinib on bone microenvironment

2016 - JOURNAL OF CLINICAL ONCOLOGY
Pantano, Francesco; Fioramonti, Marco; Iuliani, Michele; Ribelli, Giulia; Vincenzi, Bruno; Tonini, Giuseppe; Santini, Daniele

{PD}-1/{PD}-L1 expression and regorafenib clinical efficacy on refractory pancreatic cancer patient

2016 - JOURNAL OF CLINICAL ONCOLOGY
Varchetta, Veronica; Montagnese, Fabrizio; Sibio, Simone; Sica, Giuseppe; Muscaritoli, Maurizio; Soda, Giuseppe; Giordano, Gianfranco; Brandi, Rita; Tarsi, Silvia; Mancuso, Giuseppina; Petricca Mancuso, Andrea

Prognostic role of expression levels of FABP3 and AKR1B10 genes in adenocarcinoma stage I patients

2015 - JOURNAL OF CLINICAL ONCOLOGY
Ludovini, V; Siggillino, A; Bianconi, Fortunato; Pistola, L; Chiari, R; Metro, Giulio; Tofanetti, Fr; Vannucci, Jacopo; Treggiari, S; Bellezza, Guido; Sidoni, Angelo; Puma, Francesco; Crino, L.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma